Why Moderna Stock Rose 15.4% in July
Thursday, 6 August 2020 ()
Clinical trial data and progress in the coronavirus vaccine program drove the shares higher.
Why Moderna Stock Rose 15.4% in July
Thursday, 6 August 2020 ()
Clinical trial data and progress in the coronavirus vaccine program drove the shares higher. |
|
|||